The GRPR pathway is known to interact with the EGFR pathway in lung cancer cells by increasing the release of EGFR ligands such as amphiregulin [8], which could act to further promote cancer in never smokers who develop EGFR mutations. The gene discussed is EGFR; the disease is lung carcinoma.